Is EVAR a viable option in CTD? Dr. Wanhainen weighs in

In this insightful interview carried out during Critical Issues 2025, Dr. Anders Wanhainen discusses the findings of the EVICTUS study on endovascular repair (EVAR) in patients with connective tissue disorders (CTD).

Despite the cohort’s heterogeneity, the study reveals promising short- and medium-term results, suggesting that EVAR could be a viable option for treating complex aortic disease in CTD patients.

Dr. Wanhainen provides valuable insights into why this approach should be considered, especially in the context of challenging cases.

Watch now to find out more.